Piramal Pharma Solutions Sets New Benchmarks in Quality Assurance
Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), recently announced an impressive achievement: conducting over 200 customer audits in the past year and receiving more than 70 regulatory approvals across its global network. This milestone underscores the company's unwavering commitment to quality and operational excellence.
Commitment to Quality and Compliance
The robust performance of PPS is a clear reflection of its long-term quality strategy, which prioritizes sustainable compliance, continuous audit readiness, and operational efficiency. The initiatives implemented by PPS include strengthening corporate governance, promoting a quality culture, and advancing the skillset of its workforce, all within the framework of a comprehensive digital transformation plan.
According to Rashida Najmi, Chief Quality Officer at Piramal Pharma Limited, the success story of PPS is not merely about passing audits but integrating quality into the daily operations of the company. This entails maintaining audit readiness as an ongoing process rather than a sporadic occurrence. Such discipline is vital for ensuring the consistency and reliability that customers expect from PPS.
Strategy Highlights
The backbone of PPS's quality strategy revolves around several key elements:
- - Governance Framework: A comprehensive quality governance framework ensures organizational compliance and operational effectiveness.
- - Predictive Quality Tools: These tools evaluate site readiness and compliance status proactively, allowing the company to adapt to changing regulatory demands rapidly.
- - Custom Tailored Systems: PPS has implemented tailored systems that boost efficiency while reducing costs associated with quality issues.
- - RESOLVE Program: The program focuses on promoting a